ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC.

March 17, 2006

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

DuBois Succeeds Hait As AACR President, Jacks Is President-Elect.

April 18, 2008